BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33058692)

  • 1. Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future.
    Liang WH; Federico SM; London WB; Naranjo A; Irwin MS; Volchenboum SL; Cohn SL
    JCO Clin Cancer Inform; 2020 Oct; 4():895-905. PubMed ID: 33058692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
    Cohn SL; Pearson AD; London WB; Monclair T; Ambros PF; Brodeur GM; Faldum A; Hero B; Iehara T; Machin D; Mosseri V; Simon T; Garaventa A; Castel V; Matthay KK;
    J Clin Oncol; 2009 Jan; 27(2):289-97. PubMed ID: 19047291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.
    Monclair T; Brodeur GM; Ambros PF; Brisse HJ; Cecchetto G; Holmes K; Kaneko M; London WB; Matthay KK; Nuchtern JG; von Schweinitz D; Simon T; Cohn SL; Pearson AD;
    J Clin Oncol; 2009 Jan; 27(2):298-303. PubMed ID: 19047290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.
    Ambros PF; Ambros IM; Brodeur GM; Haber M; Khan J; Nakagawara A; Schleiermacher G; Speleman F; Spitz R; London WB; Cohn SL; Pearson AD; Maris JM
    Br J Cancer; 2009 May; 100(9):1471-82. PubMed ID: 19401703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.
    Naranjo A; Irwin MS; Hogarty MD; Cohn SL; Park JR; London WB
    JCO Clin Cancer Inform; 2018 Dec; 2():1-15. PubMed ID: 30652588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.
    Irwin MS; Naranjo A; Zhang FF; Cohn SL; London WB; Gastier-Foster JM; Ramirez NC; Pfau R; Reshmi S; Wagner E; Nuchtern J; Asgharzadeh S; Shimada H; Maris JM; Bagatell R; Park JR; Hogarty MD
    J Clin Oncol; 2021 Oct; 39(29):3229-3241. PubMed ID: 34319759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project.
    Sokol E; Desai AV; Applebaum MA; Valteau-Couanet D; Park JR; Pearson ADJ; Schleiermacher G; Irwin MS; Hogarty M; Naranjo A; Volchenboum S; Cohn SL; London WB
    J Clin Oncol; 2020 Jun; 38(17):1906-1918. PubMed ID: 32315273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging neuroblastoma: what the radiologist needs to know.
    McCarville MB
    Cancer Imaging; 2011 Oct; 11 Spec No A(1A):S44-7. PubMed ID: 22187096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
    Owens C; Irwin M
    Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of neuroblastoma image-defined risk factors on magnetic resonance imaging.
    Chen AM; Trout AT; Towbin AJ
    Pediatr Radiol; 2018 Aug; 48(9):1337-1347. PubMed ID: 30078048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
    Matthay KK; Shulkin B; Ladenstein R; Michon J; Giammarile F; Lewington V; Pearson AD; Cohn SL
    Br J Cancer; 2010 Apr; 102(9):1319-26. PubMed ID: 20424613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma.
    Maris JM; Hogarty MD; Bagatell R; Cohn SL
    Lancet; 2007 Jun; 369(9579):2106-20. PubMed ID: 17586306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview and recent advances in the treatment of neuroblastoma.
    Whittle SB; Smith V; Doherty E; Zhao S; McCarty S; Zage PE
    Expert Rev Anticancer Ther; 2017 Apr; 17(4):369-386. PubMed ID: 28142287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroblastoma image-defined risk factors in adrenal neuroblastoma: role of radiologist.
    Lanza C; Galeazzi V; Carboni N; De Berardinis A; De Marino L; Barile A; Giovagnoni A
    Gland Surg; 2019 Sep; 8(Suppl 3):S168-S177. PubMed ID: 31559184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
    Pinto NR; Applebaum MA; Volchenboum SL; Matthay KK; London WB; Ambros PF; Nakagawara A; Berthold F; Schleiermacher G; Park JR; Valteau-Couanet D; Pearson AD; Cohn SL
    J Clin Oncol; 2015 Sep; 33(27):3008-17. PubMed ID: 26304901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.
    Brisse HJ; McCarville MB; Granata C; Krug KB; Wootton-Gorges SL; Kanegawa K; Giammarile F; Schmidt M; Shulkin BL; Matthay KK; Lewington VJ; Sarnacki S; Hero B; Kaneko M; London WB; Pearson AD; Cohn SL; Monclair T;
    Radiology; 2011 Oct; 261(1):243-57. PubMed ID: 21586679
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Bhardwaj N; Rohilla M; Trehan A; Bansal D; Kakkar N; Srinivasan R
    J Clin Pathol; 2023 Sep; 76(9):599-605. PubMed ID: 35414524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of image-defined risk factors with clinical features, tumor biology, and outcomes in neuroblastoma: a single-center retrospective study.
    Yang DD; Liu C; Gao J; Hu QJ; Liang Y; Liu J
    Eur J Pediatr; 2023 May; 182(5):2189-2196. PubMed ID: 36856889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
    Vo KT; DuBois SG; Neuhaus J; Braunstein SE; Weil BR; Naranjo A; Irtan S; Balaguer J; Matthay KK
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29616. PubMed ID: 35188340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children's Cancer Group Neuroblastoma Committee (JCCG-JNBSG).
    Ohira M; Nakamura Y; Takimoto T; Nakazawa A; Hishiki T; Matsumoto K; Shichino H; Iehara T; Nagase H; Fukushima T; Yoneda A; Tajiri T; Nakagawara A; Kamijo T
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.